Z. Ş. Sevinçli Et Al. , "Anticancer and antituberculosis effects of 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones," ISTANBUL JOURNAL OF PHARMACY , vol.50, no.3, pp.176-180, 2020
Sevinçli, Z. Ş. Et Al. 2020. Anticancer and antituberculosis effects of 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones. ISTANBUL JOURNAL OF PHARMACY , vol.50, no.3 , 176-180.
Sevinçli, Z. Ş., Canturk, Z., Dikmen, M., & KARALI, N. L., (2020). Anticancer and antituberculosis effects of 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones. ISTANBUL JOURNAL OF PHARMACY , vol.50, no.3, 176-180.
Sevinçli, Zekiye Et Al. "Anticancer and antituberculosis effects of 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones," ISTANBUL JOURNAL OF PHARMACY , vol.50, no.3, 176-180, 2020
Sevinçli, Zekiye Ş. Et Al. "Anticancer and antituberculosis effects of 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones." ISTANBUL JOURNAL OF PHARMACY , vol.50, no.3, pp.176-180, 2020
Sevinçli, Z. Ş. Et Al. (2020) . "Anticancer and antituberculosis effects of 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones." ISTANBUL JOURNAL OF PHARMACY , vol.50, no.3, pp.176-180.
@article{article, author={Zekiye Şeyma Sevinçli Et Al. }, title={Anticancer and antituberculosis effects of 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones}, journal={ISTANBUL JOURNAL OF PHARMACY}, year=2020, pages={176-180} }